GALT
#3069
Galectin Therapeutics Inc. - Common Stock
4.0 2 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.90%
Monthly Change
+14.53%
6 month change
+34.90%
Year Change
-6.07%
Previous Close
4.1 4
Open
4.0 2
Low
4.0 2
High
4.0 2
Volume
40
Financials
- Market Capitalization 405.42 M
- Employee 9
- Founded 2000
- CEO N/A
- Website www.galectintherapeutics.com
- Headquarter Nevada, United States
- FIGI BBG000BK6FP5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.67
Price to sales ratio
-74.93
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3035 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.86 USD | +6.63% | +9.35% | +22.93% | +18.04% | 423.73 M USD | ||
| 3050 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 4.01 USD | -0.99% | -5.20% | +9.86% | +9.56% | 416.57 M USD | ||
| 3076 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | -4.49% | +0.25% | +2.02% | +36.03% | 400.55 M USD | ||
| 3079 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.86 USD | -2.61% | -0.41% | +11.47% | +1.89% | 398.74 M USD |
Frequently asked questions about Galectin Therapeutics Inc.
What is the Galectin Therapeutics Inc. stock price today?
The current price of Galectin Therapeutics Inc. (GALT) is 4.02. Over the past 24 hours, the stock has changed by -2.90%. Follow the GALT chart for real-time price dynamics.
What is the stock ticker of Galectin Therapeutics Inc.?
Galectin Therapeutics Inc. trades under the ticker GALT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Galectin Therapeutics Inc. stock going up?
GALT has changed by +9.24% over the last week, +14.53% over the last month, and -6.07% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Galectin Therapeutics Inc.?
Galectin Therapeutics Inc. currently has a market capitalization of 405.42 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Galectin Therapeutics Inc. earnings last quarter?
Last quarter, Galectin Therapeutics Inc. reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Galectin Therapeutics Inc. revenue for the last quarter?
Galectin Therapeutics Inc. reported quarterly revenue of -3.15 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Galectin Therapeutics Inc. net income for the last quarter?
Galectin Therapeutics Inc. reported net income of -9.11 M for the last quarter. The previous quarter showed -5.05 M, which means net income changed by -80.60%.
How many employees does Galectin Therapeutics Inc. have?
As of the latest available data, Galectin Therapeutics Inc. has 9 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Galectin Therapeutics Inc. stock?
You can buy Galectin Therapeutics Inc. (GALT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Galectin Therapeutics Inc. stock?
Investing in Galectin Therapeutics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GALT chart and related analysis on metatrader.com as part of your research.